Skip to main content
OpenTrials
Completed

NCT Number: NCT07471113

Mobile App-Supported HPV and Breast Cancer Awareness Program

The goal of this study is to learn about the impact of a mobile application-supported education program on women's HPV literacy and their beliefs regarding breast cancer screening. The main questions it aims to answer are:

* Does a mobile application-supported program increase HPV literacy levels among women? * Does this intervention strengthen women's positive beliefs and attitudes toward breast cancer screening? Researchers will examine how this holistic, health-based intervention changes participants' awareness and screening perspectives.

Participants will:

* Use a mobile application designed to provide education on HPV and breast cancer * Complete surveys regarding their HPV knowledge and breast cancer screening beliefs before and after the program * Engage with health-related content through the mobile platform for the duration of the study.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This study aims to evaluate the effect of a mobile application-supported Human Papillomavirus (HPV) and breast cancer program on HPV literacy and breast cancer screening beliefs among women attending primary health care services.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • -Women aged 30-65 years
  • -Literate (able to read and write)
  • -Able to understand and speak Turkish
  • -Able to use a smartphone
  • -Willing to use the mobile application during the study period and consent to data sharing

Exclusion criteria

  • Having undergone regular breast cancer (mammography) and/or cervical cancer (Pap smear/HPV DNA test) screening within the last 3 years, in accordance with national screening guidelines
  • Previous diagnosis of any cancer
  • Neurological conditions affecting cognitive function (e.g., dementia, Alzheimer's disease) or physical/psychiatric conditions that would seriously limit study participation and mobile app use
  • Pregnancy or breastfeeding
  • Participation in another health-related research study during the study period

Treatment and study plan

Mobile application

Behavioral

A mobile application will be implemented for this group.

Primary outcomes

  1. Change in HPV literacy (HPV-LS total score) from baseline (pretest) to post-intervention (posttest) compared between the Mobile Application-Supported Education Group and the Control Group.

    Time frame: 12 MONTH

    The primary outcome is the change in participants' HPV literacy as measured by the HPV Literacy Scale (HPV; 24 items, 5-point Likert). Total scores range from 24 to 120, with higher scores indicating higher HPV literacy. The outcome will be assessed at baseline (pretest) and post-intervention (posttest) and compared between groups.

  2. Change in breast cancer screening beliefs (Breast Cancer Screening Beliefs Scale total score and/or subscale scores) from baseline to post-intervention compared between groups.

    Time frame: 12 MONTH

    Breast Cancer Screening Beliefs: The primary outcome is the change in breast cancer screening beliefs measured by the Breast Cancer Screening Beliefs Scale (13 items, 5-point Likert; transformed scoring 0-100). Higher scores indicate more positive screening beliefs (more favorable attitudes/knowledge and fewer perceived barriers). The outcome will be assessed at baseline (pretest) and post-intervention (posttest) and compared between groups.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

The Impact of a Mobile App-Supported Human Papilloma Virus and Breast Cancer Program on HPV Literacy and Breast Cancer Screening Beliefs

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Mar 13, 2026
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.